Mátyás Keltai
ORCID：0000-0002-5465-163X
发表论文 169 篇 · 总被引 26286 次 · h-index 55
代表论文
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial (2019 · The Lancet · 被引 3178)
- Initial Invasive or Conservative Strategy for Stable Coronary Disease (2020 · New England Journal of Medicine · 被引 2463)
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease (2017 · New England Journal of Medicine · 被引 2457)
- Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial (2019 · The Lancet · 被引 645)
- Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin (2019 · Gastroenterology · 被引 484)
- Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial (2020 · The Lancet Neurology · 被引 291)